WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Paris, France · Founded 2019 · $36.0M raised

Headquarters
Paris
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$36.0M
Last Round
$26.0M Series BOct 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

WhiteLab Genomics stands at the convergence of AI and biology. Founded in 2019 and backed by Y-Combinator, the company is pioneering the accelerated development of life-saving genomic medicines. By leveraging proprietary technology, WhiteLab Genomics uses AI and advanced computational methods to analyze complex biological data to significantly accelerate and de-risk drug development. The company improves therapeutic target discovery and delivery by predicting the optimal molecular design for specific target product profiles to expedite and de-risk the development of genomic medicines.

Summary

WhiteLab Genomics is an Artificial Intelligence company based in Paris, France, founded in 2019. It has raised $36.0M in total across 2 rounds, most recently a $26.0M Series B round in Oct 2026. Investors include Omnes Capital, Debiopharm Innovation and Alven.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2026
$26.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Intelligent Medical Objects

IMO Health provides clinical data intelligence that helps healthcare organizations turn complex c...

Rosemont, United States201–500Artificial Intelligence, Healthcare
Private EquityTotal funding$1.5BMar 2022
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
EdifecsAcquired

Edifecs delivers healthcare technology that unifies data for nearly 300 million people, powering ...

Bellevue, United States1001–5000Artificial Intelligence, Healthcare
Growth EquityTotal funding$1.4BJul 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

WhiteLab Genomics on Indexed.vc
<a href="https://indexed.vc/companies/whitelabgenomics"><img src="https://indexed.vc/api/badge/company/whitelabgenomics" alt="WhiteLab Genomics on Indexed.vc" width="260" height="76" /></a>